Terms: = Pancreatic cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
31 results:
1. Serum Biomarkers of Nociceptive and Neuropathic Pain in Chronic Pancreatitis.
Saloman JL; Li Y; Stello K; Li W; Li S; Phillips AE; Hall K; Fogel EL; Vege SS; Li L; Andersen DK; Fisher WE; Forsmark CE; Hart PA; Pandol SJ; Park WG; Topazian MD; Van Den Eeden SK; Serrano J; Conwell DL; Yadav D;
J Pain; 2023 Dec; 24(12):2199-2210. PubMed ID: 37451493
[TBL] [Abstract] [Full Text] [Related]
2. gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
Pozios I; Hering NA; Guenzler E; Arndt M; Elezkurtaj S; Knösel T; Bruns CJ; Margonis GA; Beyer K; Seeliger H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):271-280. PubMed ID: 36495330
[TBL] [Abstract] [Full Text] [Related]
3. Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver cancer via Inhibition of STAT3.
Zhu X; Song G; Zhang S; Chen J; Hu X; Zhu H; Jia X; Li Z; Song W; Chen J; Jin C; Zhou M; Zhao Y; Xie H; Zheng S; Song P
Cancer Res; 2022 Nov; 82(21):3987-4000. PubMed ID: 36043912
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer.
Suzuki H; Mitsunaga S; Ikeda M; Aoyama T; Yoshizawa K; Yamaguchi M; Suzuki M; Narita M; Kawasaki T; Ochiai A
Cancer Med; 2022 Dec; 11(24):5001-5012. PubMed ID: 35578571
[TBL] [Abstract] [Full Text] [Related]
5. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling.
Huo Y; Yang J; Zheng J; Xu D; Yang M; Tao L; Yao H; Fu X; Yang J; Liu D; Hua R; Zhang J; Sun Y; Hu L; Liu W
Cell Prolif; 2022 May; 55(5):e13237. PubMed ID: 35487760
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
Peisl S; Mellenthin C; Vignot L; Gonelle-Gispert C; Bühler L; Egger B
PLoS One; 2021; 16(6):e0252397. PubMed ID: 34138876
[TBL] [Abstract] [Full Text] [Related]
7. Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy.
Ishii T; Suzuki A; Kuwata T; Hisamitsu S; Hashimoto H; Ohara Y; Yanagihara K; Mitsunaga S; Yoshino T; Kinoshita T; Ochiai A; Shitara K; Ishii G
Gastric Cancer; 2021 Jul; 24(4):810-822. PubMed ID: 33837489
[TBL] [Abstract] [Full Text] [Related]
8. Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis.
Aftabizadeh M; Li YJ; Zhao Q; Zhang C; Ambaye N; Song J; Nagao T; Lahtz C; Fakih M; Ann DK; Yu H; Herrmann A
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491667
[TBL] [Abstract] [Full Text] [Related]
9. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract] [Full Text] [Related]
10. Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.
Liu C; Deng S; Jin K; Gong Y; Cheng H; Fan Z; Qian Y; Huang Q; Ni Q; Luo G; Yu X
Int J Oncol; 2020 Apr; 56(4):900-908. PubMed ID: 32319567
[TBL] [Abstract] [Full Text] [Related]
11. B cell-Derived IL35 Drives STAT3-Dependent CD8
Mirlekar B; Michaud D; Lee SJ; Kren NP; Harris C; Greene K; Goldman EC; Gupta GP; Fields RC; Hawkins WG; DeNardo DG; Rashid NU; Yeh JJ; McRee AJ; Vincent BG; Vignali DAA; Pylayeva-Gupta Y
Cancer Immunol Res; 2020 Mar; 8(3):292-308. PubMed ID: 32024640
[TBL] [Abstract] [Full Text] [Related]
12. Broadening horizons with
Ballal S; Yadav MP; Bal C; Sahoo RK; Tripathi M
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):934-946. PubMed ID: 31707430
[TBL] [Abstract] [Full Text] [Related]
13. Blocking IL-6/gp130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human pancreatic cancer Cells.
Chen X; Tian J; Su GH; Lin J
Curr Cancer Drug Targets; 2019; 19(5):417-427. PubMed ID: 29714141
[TBL] [Abstract] [Full Text] [Related]
14. cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.
Ma J; Song X; Xu X; Mou Y
Cancer Res Treat; 2019 Jan; 51(1):194-210. PubMed ID: 29690750
[TBL] [Abstract] [Full Text] [Related]
15. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract] [Full Text] [Related]
16. LIF Drives Neural Remodeling in pancreatic cancer and Offers a New Candidate Biomarker.
Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R
Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518
[TBL] [Abstract] [Full Text] [Related]
17. Interleukin 35 Expression Correlates With Microvessel Density in pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract] [Full Text] [Related]
18. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
Mi F; Gong L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
[TBL] [Abstract] [Full Text] [Related]
19. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression.
Huang C; Li N; Li Z; Chang A; Chen Y; Zhao T; Li Y; Wang X; Zhang W; Wang Z; Luo L; Shi J; Yang S; Ren H; Hao J
Nat Commun; 2017 Jan; 8():14035. PubMed ID: 28102193
[TBL] [Abstract] [Full Text] [Related]
20. Bazedoxifene as a Novel gp130 Inhibitor for pancreatic cancer Therapy.
Wu X; Cao Y; Xiao H; Li C; Lin J
Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
[TBL] [Abstract] [Full Text] [Related]
[Next]
